ArticlePloS one2025
Utilization of modern contraceptive methods among women of reproductive age in Senegal: A multilevel mixed-effects analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transitions between contraceptive states among women aged 15-49 Years in Guinea.Public health in practice (Oxford, England) · 2026Article
- When choice is not performative: the struggle for agency among women accessing family planning services in Senegal.Frontiers in global women's health · 2026Article
- Acceptability and utilization of modern contraceptives and associated factors among childbearing-aged women in Northern Ghana: a cross-sectional study.Contraception and reproductive medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite high fertility rates in low- and middle-income countries, modern contraceptive use remains low. In Senegal, there is limited use of modern contraceptives, and few studies have explored the factors influencing their adoption. This study aims to identify the determinants of modern contraceptive use among women of reproductive age in Senegal.
methodData from the 2023 Senegal Demographic and Health Survey, covering 8,833 women, were analyzed using a multilevel logistic regression model to identify factors associated with modern contraceptive use. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were used, and statistical significance was set at p < 0.05. Analysis was conducted using STATA version 17.
resultsThe utilization of modern contraceptives among reproductive-aged women in Senegal was 32.16% (95% CI: 31.19, 33.15). Significant factors associated with its use included age (25-34: AOR = 1.46, 35-44: AOR = 1.59, > 44: AOR = 1.72), secondary education (AOR = 1.19), employment (AOR = 1.38), being undecided about having more children (AOR = 1.39), not wanting more children (AOR = 2.42), age at first sex (≥18: AOR = 1.16), and first birth (≥19: AOR = 0.65). Other factors include being visited by a field worker (AOR = 1.32), visiting a health facility (AOR = 2.04), media exposure (AOR = 1.42), higher household income (middle: AOR = 1.23, rich: AOR = 1.38), and having one or more births (one: AOR = 2.06, two or more: AOR = 1.72). Women living in rural areas (AOR = 0.75) or in regions such as Ziguinchor (AOR = 0.60), Diourbel (AOR = 0.50), Tambacounda (AOR = 0.27), Louga (AOR = 0.61), Matam (AOR = 0.37), Kédougou (AOR = 0.64), and Sédhiou (AOR = 0.67) were less likely to use contraceptives.
conclusionFactors such as age, education, employment, media exposure, and healthcare access are critical determinants of modern contraceptive use in Senegal. Women in rural areas and specific regions face barriers to contraceptive use. Targeted interventions in these areas could enhance family planning and reproductive health outcomes in Senegal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.